지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Objectives: In this preliminary study, we investigated the clinical characteristics of patients who were first diagnosed with psychotic disorder and explored the impact of the adherence to antipsychotics on long-term medical use. Methods: All national health insurance claims related to psychotic disorders including gender, age, income, and drug compliance, from January 1, 2008 to December 31, 2015, were examined. With trend test using Medication Possession Ratio (MPR), we compared the medical use between the compliant group (MRP≥0.8) and the comparative non-compliant group (0.2≤MPR＜0.8). Results: Among 28,095 participants in total, 16,239 patients (57.8%) were diagnosed as schizophrenia; the 30s were the most common (n=7,151, 25.5%). Drug compliance was generally low regardless of the diagnosis and was the lowest among 20s with the 4060% range of income. The compliant group showed lower psychiatric and medical use than the comparative group in the following years (p＜0.0001). Conclusion: These findings suggest that patients in the 20s and 30s with the 40-60% range of income, who are diagnosed with schizophrenia at the first psychiatric visit, may need more clinical and political attention. The results also emphasize the importance of initial drug adherence to antipsychotics in reducing long-term psychiatric costs.
목차
등록된 정보가 없습니다.
참고문헌 (41)
참고문헌 신청
American Psychiatric Association / 2013 / Diagnostic and statistical manual of mental disorders / Hakjisa :93~94
National Collaborating Centre for Mental Health / 2014 / National Institute for Health and Clinical Excellence: Guidance. Psychosis and Schizophrenia in Adults: Treatment and Management: Updated Edition 2014 / National Institute for Health and Care Excellence :14~15
Keshavan MS / 2011 / Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse / Schizophr Res 127:3~13
Lehman AF / 2004 / Practice guideline for the treatment of patients with schizophrenia / Am J Psychiatry :161
Kreyenbuhl J / 2010 / The schizophrenia patient outcomes research team (PORT): updated treatment recommendations. 2009 / Schizophr Bull 36:94~103
National Collaborating Centre for Mental Health / 2014 / National Institute for Health and Clinical Excellence: Guidance. Psychosis and Schizophrenia in Adults: Treatment and Management: Updated Edition 2014 / National Institute for Health and Care Excellence :14~15
Keshavan MS / 2011 / Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse / Schizophr Res 127:3~13
Lehman AF / 2004 / Practice guideline for the treatment of patients with schizophrenia / Am J Psychiatry :161
Kreyenbuhl J / 2010 / The schizophrenia patient outcomes research team (PORT): updated treatment recommendations. 2009 / Schizophr Bull 36:94~103
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
항정신병약물 임상의 역사와 미래
신경정신의학
2019 .01
-
Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics
Clinical Psychopharmacology and Neuroscience
2021 .01
-
조현병 환자에서 항정신병약물 유지치료 시 치료결과에 대한 연구
대한조현병학회지
2017 .10
-
노인환자의 항정신병 약물 원외처방 내역에 미친 영향 요인 분석
한국임상약학회지
2021 .12
-
항정신병약물의 생물학적 기전 최신 지견
신경정신의학
2019 .01
-
조현병을 처음 진단받은 환자들의 초기 투약 순응도에 따른 발병 1년 후 임상 결과: 국민건강보험공단 자료에 기반한 후향적 코호트 연구
대한조현병학회지
2023 .04
-
Understanding of Antipsychotics in Elderly Patients with Dementia
Dementia and Neurocognitive Disorders(대한치매학회지)
2015 .01
-
A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder
Clinical Psychopharmacology and Neuroscience
2015 .01
-
양극성장애에서 Antipsychotics의 사용 전략
신경정신의학
2018 .01
-
조현병 약물치료의 최신 지견
대한의사협회지
2024 .02
-
Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison
Clinical Psychopharmacology and Neuroscience
2015 .01
-
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
Clinical Psychopharmacology and Neuroscience
2021 .11
-
Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge
Clinical Psychopharmacology and Neuroscience
2019 .01
-
치료 위저항성 조현병: 치료 비순응을 중심으로
대한조현병학회지
2020 .01
-
Target Discovery Using Deep Learning-Based Molecular Docking and Predicted Protein Structures With AlphaFold for Novel Antipsychotics
PSYCHIATRY INVESTIGATION
2023 .06
-
Diabetic Ketoacidosis Associated With Second Generation Antipsychotics: A Case Study and Review of Literature
PSYCHIATRY INVESTIGATION
2024 .02
-
Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
Clinical Psychopharmacology and Neuroscience
2020 .01
-
항정신병 약물의 병용요법을 사용 중인 환자들에서 아리피프라졸 장기 지속형 주사제의 효능
생물치료정신의학
2024 .10
-
Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
Clinical Psychopharmacology and Neuroscience
2017 .01
-
Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study
PSYCHIATRY INVESTIGATION
2024 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0